<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Carboplatin; Cisplatin; Oxaliplatin" /><meta name="IX" content="Carboplatin; Cisplatin; Oxaliplatin" /><title>Platinum compounds: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="67743.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="67743.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=67743.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2075.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="4676.htm">8.1 Cytotoxic drugs</a> &gt; <a href="4758.htm">8.1.5 Other antineoplastic drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="11781.htm" title="Previous: PENTOSTATIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="11760.htm" title="Next: CARBOPLATIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a395017.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a384036.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a302033.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/16564-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Carboplatin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: C &gt; Interactions of Carboplatin</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/1822-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Cisplatin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: C &gt; Interactions of Cisplatin</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/2972-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Oxaliplatin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: O &gt; Interactions of Oxaliplatin</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="11760.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CARBOPLATIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds</p></div></li><li><a href="36785.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds &gt; CARBOPLATIN</p></div></li><li><a href="11766.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CISPLATIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22carboplatin%22%22cisplatin%22%22oxaliplatin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>BNF for Children (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/67743.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Platinum compounds</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/11760.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CARBOPLATIN</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/36785.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Platinum compounds &gt; CARBOPLATIN</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22carboplatin%22%22cisplatin%22%22oxaliplatin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e255581.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1230.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; O</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a589006.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a582041.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a506013.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0003s0085.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0003s0555.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0014s0090.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/16564-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1822-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/2972-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/01822.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carboplatin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; C &gt; CA</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/02317.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cisplatin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; C &gt; CI</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06912.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxaliplatin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; O &gt; OX</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E30E3E0R0D707.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Carboplatin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E14E3E0R0D577.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Cisplatin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D1577.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Oxaliplatin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; O</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_67743">Platinum compounds</h1><?highlighter on?><div id="pC" class="jN"><div><div id="_1199888698259"><p><b><span>Carboplatin</span></b> is widely used in
the treatment of advanced ovarian cancer and lung cancer (particularly
the small cell type). It is given <i>intravenously</i>.
The dose of <span>carboplatin</span> is determined according
to renal function rather than body surface area. <span>Carboplatin</span> can be given on an outpatient basis and is better tolerated than <span>cisplatin</span>; nausea and vomiting are reduced in severity
and nephrotoxicity, neurotoxicity, and ototoxicity are much less of
a problem than with <span>cisplatin</span>. It is, however,
more myelosuppressive than <span>cisplatin</span>.</p></div><div id="_1199888725541"><p><b><span>Cisplatin</span> </b> is used alone or in combination for
the treatment of testicular, lung, cervical, bladder, head and neck,
and ovarian cancer (but carboplatin is preferred for ovarian cancer).
It is given <i>intravenously</i>. <span id="_67743.7"><span>Cisplatin</span> requires intensive intravenous hydration and treatment
may be complicated by severe nausea and vomiting. <span>Cisplatin</span> is toxic, causing nephrotoxicity (monitoring of renal
function is essential)</span>, ototoxicity, peripheral
neuropathy, hypomagnesaemia and myelosuppression. It is, however,
increasingly given in a day-care setting.</p></div><div id="_1199888745917"><p><b><span>Oxaliplatin</span></b> is licensed in combination with <span>fluorouracil</span> and folinic acid, for the treatment of metastatic
colorectal cancer and as adjuvant treatment of colon cancer after
resection of the primary tumour; it is given by intravenous infusion. <span id="_67743.6">Neurotoxic side-effects (including
sensory peripheral neuropathy) are dose limiting</span>. Other
side-effects include gastro-intestinal disturbances, ototoxicity,
and myelosuppression. <span id="_67743.5">If unexplained respiratory
symptoms occur, oxaliplatin should be discontinued until investigations
exclude interstitial lung disease and pulmonary fibrosis</span>.</p></div><div id="_67743.2"><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Irinotecan, oxaliplatin, and raltitrexed for advanced
colorectal cancer (August 2005)</h3><p>A combination of fluorouracil and folinic acid with either irinotecan
or oxaliplatin are options for first-line treatment for advanced colorectal
cancer.</p><p>Irinotecan alone or  fluorouracil and folinic acid with oxaliplatin
are options for patients who require further treatment subsequently.</p><p>Raltitrexed is <b>not</b> recommended for the treatment
of advanced colorectal cancer. Its use should be confined to clinical
studies.</p></div><div class="cN"><h3 class="cBP">NICE guidance (capecitabine and oxaliplatin in the
adjuvant treatment of stage III (Dukes’ C) colon cancer)</h3><p>See <a title="target-block: NICE guidance, Dukes C colon cancer" href="4725.htm#_4725.10">Antimetabolites</a></p></div></div><div id="_67743.4"><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Paclitaxel for ovarian cancer (January 2003)</h3><p><i>Either</i> paclitaxel in combination with a platinum
compound (cisplatin or carboplatin) <i>or</i> a platinum
compound alone are alternatives for the first-line treatment of ovarian
cancer (usually following surgery).</p></div></div><div id="_67743.3"><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Paclitaxel, pegylated liposomal doxorubicin, and
topotecan for second-line or subsequent treatment of advanced ovarian
cancer (May 2005)</h3><p>Paclitaxel, combined with a platinum compound (carboplatin or
cisplatin), is an option for advanced cancer that relapses 6 months
or more after completing initial platinum-based chemotherapy. Paclitaxel
alone is an option for advanced ovarian cancer that does not respond
to, or relapses within 6 months of completing initial platinum-based
chemotherapy.</p><p>Pegylated liposomal doxorubicin is an option for advanced ovarian
cancer that does not respond to, or relapses within 12 months of completing
initial platinum-based chemotherapy.</p><p>Paclitaxel alone or pegylated liposomal doxorubicin are options
for advanced ovarian cancer in patients who are allergic to platinum
compounds. Topotecan alone is an option only for advanced ovarian
cancer that does not respond to, or relapses within 6 months of completing
initial platinum-based chemotherapy or in those allergic to platinum
compounds <i>and</i> for whom paclitaxel alone or pegylated
liposomal doxorubicin are inappropriate.</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_11760"><a href="11760.htm" title="CARBOPLATIN">CARBOPLATIN</a></li><li id="_11766"><a href="11766.htm" title="CISPLATIN">CISPLATIN</a></li><li id="_81882"><a href="81882.htm" title="OXALIPLATIN">OXALIPLATIN</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="11781.htm">Previous: PENTOSTATIN</a> | <a class="top" href="67743.htm#">Top</a> | <a accesskey="]" href="11760.htm">Next: CARBOPLATIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>